GeneDx Holdings (WGSWW) EPS (Weighted Average and Diluted) (2020 - 2026)
GeneDx Holdings (WGSWW) reported EPS (Weighted Average and Diluted) of -$2.16 for Q1 2026, down 839.13% year-over-year from $0.29 in Q1 2025, and down 254.1% quarter-over-quarter from -$0.61 in Q4 2025.
GeneDx Holdings (WGSWW) EPS (Weighted Average and Diluted) (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGSWW) has 7 years of EPS (Weighted Average and Diluted) data on file, last reported at -$2.16 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$2.16, down 839.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.68 (down 90.07% YoY), and the FY2025 annual result was -$0.73, up 62.37% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$2.16 in Q1 2026 per WGSWW's latest filing, from -$0.61 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.36 in Q2 2025 and troughed at -$28.97 in Q4 2022.
- A 5-year average of -$3.93 and a median of -$1.1 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2025: EPS (Weighted Average and Diluted) plunged 4300.0% in 2022, then jumped 132.73% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$28.97 in 2022, then soared by 96.82% to -$0.92 in 2023, then jumped by 125.0% to $0.23 in 2024, then slumped by 365.22% to -$0.61 in 2025, then sank by 254.1% to -$2.16 in 2026.
- Business Quant data shows WGSWW's EPS (Weighted Average and Diluted) at -$2.16 in Q1 2026, -$0.61 in Q4 2025, and -$0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.20 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -0.60 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.61 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 8.33 |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | -2.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.16 |
| Dec 31, 2025 | -0.61 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | 0.36 |
| Mar 31, 2025 | -0.23 |
| Dec 31, 2024 | 0.23 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -1.10 |
| Mar 31, 2024 | -0.78 |
| Dec 31, 2023 | -0.92 |
| Sep 30, 2023 | -1.64 |
| Jun 30, 2023 | -1.84 |
| Mar 31, 2023 | -3.04 |
| Dec 31, 2022 | -28.97 |
| Sep 30, 2022 | -6.72 |
| Jun 30, 2022 | -8.38 |
| Mar 31, 2022 | -10.38 |
| Dec 31, 2021 | 0.98 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | -41.94 |